Breaking news: Levi & Korsinsky file securities fraud class action against UroGen.

A securities fraud class action lawsuit has been filed against UroGen Pharma Ltd. by Levi & Korsinsky. The deadline for investors to join the class action is July 28, 2025. The lawsuit alleges that UroGen Pharma Ltd. made false and misleading statements regarding its business operations and financial prospects, which ultimately led to inflated stock prices. Investors who suffered losses as a result of investing in UroGen Pharma Ltd. are encouraged to participate in the class action lawsuit.

According to the lawsuit, UroGen Pharma Ltd. misrepresented the success of its drug candidates and their potential to receive regulatory approval. The company allegedly failed to disclose important information about the safety and efficacy of its products, leading investors to make decisions based on inaccurate information. As a result, the stock prices of UroGen Pharma Ltd. were artificially inflated, causing investors to suffer significant financial losses when the truth was revealed.

Investors who purchased UroGen Pharma Ltd. securities between May 5, 2017, and November 9, 2024, are eligible to join the class action lawsuit. The lawsuit seeks to recover damages on behalf of investors who were misled by the company’s false statements and omissions. By holding UroGen Pharma Ltd. accountable for its alleged misconduct, investors may be able to recoup some or all of their losses.

Levi & Korsinsky is a reputable law firm that specializes in securities litigation. The firm has a proven track record of successfully representing investors in cases of securities fraud and other financial misconduct. By filing this class action lawsuit against UroGen Pharma Ltd., Levi & Korsinsky aims to protect the rights of investors who have been harmed by the company’s alleged wrongdoing.

Investors who wish to participate in the class action lawsuit must act quickly, as the deadline to join is fast approaching. By coming forward and joining the lawsuit, investors can seek justice for the losses they have suffered due to UroGen Pharma Ltd.’s alleged securities fraud. Levi & Korsinsky is committed to fighting for the rights of investors and holding companies accountable for their actions.

If you are an investor who purchased UroGen Pharma Ltd. securities between May 5, 2017, and November 9, 2024, and suffered financial losses as a result, you may be eligible to join the class action lawsuit. Contact Levi & Korsinsky today to learn more about your legal rights and options. Time is of the essence, so don’t delay in seeking the justice you deserve.